Affiliation:
1. The University of Sydney
2. University of the Sunshine Coast
Abstract
Abstract
Chlamydiosis is a significant disease affecting Eastern Australian koala (Phascolarctos cinereus) populations, impacting individual animal welfare and fecundity and therefore influencing population dynamics. The aim of this study was to investigate the effect of a synthetic peptide vaccine based on 4 components of the Chlamydia pecorumMajor Outer Membrane Protein (MOMP), over an 18-month period in a koala severely impacted by chlamydiosis. Wild koalas were recruited into a vaccination or a placebo treatment group on a random allocation, then followed through a period of 18 months, with recapture at 6 monthly intervals. Vaccination did not alter clinical disease expression or chlamydial shedding from the ocular or urogenital sites. Vaccination did not stimulate a significant plasma anti-MOMP IgG response, when compared to the placebo group. There was no significant effect of vaccination on IFN-γ and IL-17A mRNA expression of peripheral blood lymphocytes when stimulated with rMOMP. We have demonstrated that a synthetic peptide vaccination against chlamydiosis is not an effective management tool in a koala population with a high prevalence of C. pecorum infection and related disease. The lack of antigenic response found in this study suggests that further research utilising a larger, full-length antigen is an avenue worth investigation if we are to consider vaccination as a part of a management strategy in diseased koala populations.
Publisher
Research Square Platform LLC
Reference54 articles.
1. DAWE. National Recovery plan for the Koala: Phascolarctos cinereus (combined populations of Queensland, New South Wales and the Australian Capital Territory). Department of Agriculture, Water and the Environment: Canberra, March 2022.
2. 7, P.C.N. Koala populations and habitat in New South Wales, 3 edn. Department of Planning and Environment, New South Wales Goverment: Sydney, New South Wales, 2020.
3. Genetic diversity of Chlamydia pecorum strains in wild koala locations across Australia and the implications for a recombinant C. pecorum major outer membrane protein based vaccine;Kollipara A;Vet. Microbiol.,2013
4. Genetic differences in Chlamydia pecorum between neighbouring sub-populations of koalas (Phascolarctos cinereus);Fernandez CM;Vet. Microbiol.,2019
5. Longitudinal study of wild koalas (Phascolarctos cinereus) reveals chlamydial disease progression in two thirds of infected animals;Robbins A;Sci. Rep.,2019